ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Women's health · Hum Reprod · 2026-10-01

In 438 women with recurrent miscarriage and CD138-defined chronic endometritis, preconceptual doxycycline did not improve cumulative live birth or ongoing pregnancy versus placebo (52% vs 50%; aRR 1.02, CrI 0.85–1.21). Trial stopped at interim analysis.

RCTn = 438
Odendaal et al. A double-blind multi-centre randomised placebo-controlled trial of doxycycline in women with recurrent miscarriage and chronic endometritis defined by CD138 positive stromal cells
Infectious diseases · Lancet Infect Dis · 2026-06-30

In 399 MSM at Chinese community organisations, doxy-PEP use after condomless sex at 6 months was 41% with co-created education alone vs 76% when free pay-it-forward doxy-PEP was added and 73% with added social network distribution (both p<0·0001).

RCTn = 399
Fitzpatrick et al. Community-engaged implementation strategies to increase doxycycline post-exposure prophylaxis uptake among men who have sex with men in China (DoxyForward): a three-group, open-label, randomised controlled trial
Infectious diseases · Vaccine · 2025-12-24

Phase 2 open-label RCT in 210 healthy adults: anthrax vaccine adsorbed, adjuvanted did not alter ciprofloxacin pharmacokinetics; the doxycycline Cmax equivalence endpoint was not met. Vaccine immunogenicity was non-inferior with either antibiotic.

RCTn = 210
Drobic et al. Effect of Co-administration of the anthrax vaccine adsorbed, adjuvanted with ciprofloxacin or doxycycline on antibiotic pharmacokinetics and the vaccine immunogenicity: A phase 2 drug-vaccine interaction study

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.